Tenaya Therapeutics Stock Quote TNYA - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

4.21

Bid

4.22

Ask

4.23

Volume

27,765

3.93 Day's Range 4.29

1.66 52 Week Range 8.0914

Market Cap

288.791M

Previous Close

4.21

Open

4.28

Last Trade

4.23

Last Trade Time

10:44:08

Financial Volume

$ 117,151

VWAP

4.2194

Average Volume (3m)

389,491

Shares Outstanding

68,111,019

Dividend Yield

PE Ratio

-2.33

Earnings Per Share (EPS)

-1.82

Revenue

Net Profit

-124.08M

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and p... Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.tenayatherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Tenaya Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TNYA. The last closing price for Tenaya Therapeutics was $4.21. Over the last year, Tenaya Therapeutics shares have traded in a share price range of $ 1.66 to $ 8.0914.

Tenaya Therapeutics currently has 68,111,019 shares outstanding. The market capitalization of Tenaya Therapeutics is $288.79 million. Tenaya Therapeutics has a price to earnings ratio (PE ratio) of -2.33.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Initial Data from Ongoing MyPEAK™-1 Phase 1b of TN-201 Expected in Second Half of 2024 Clinical Sites Activated for RIDGE™-1 Phase 1b Clinical Trial of TN-401 Announced Cost Containment Measures...

Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting

SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.39	-8.47826086957	4.6	4.6	3.93	343032	4.15923139	CS
4	-0.55	-11.5546218487	4.76	4.89	3.81	334554	4.33742632	CS
12	-2.1	-33.2805071315	6.31	6.47	3.81	389491	4.65049362	CS
26	2.23	112.626262626	1.98	7.01	1.865	481036	4.51604529	CS
52	-3.43	-44.8952879581	7.64	8.0914	1.66	415822	4.24633053	CS
156	-15.29	-78.4102564103	19.5	32	1.64	317946	6.20256729	CS
260	-15.29	-78.4102564103	19.5	32	1.64	317946	6.20256729	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MBOTMicrobot Medical Inc	$ 2.29 (129.00%)	86.76M
TOIIWOncology Institute Inc	$ 0.0256 (60.00%)	12.29k
AFMDAffimed NV	$ 6.75 (55.17%)	5.69M
BPTHBio Path Holdings Inc	$ 3.18 (54.37%)	45.02M
YGMZMingZhu Logistics Holdings Limited	$ 0.4336 (27.45%)	20.77M
CAMPCalAmp Corp	$ 1.0101 (-62.17%)	1.01M
INBXInhibrx Biosciences Inc	$ 16.53 (-51.54%)	81.45k
GRTXGalera Therapeutics Inc	$ 0.1455 (-32.36%)	6.52M
CNSPCNS Pharmaceuticals Inc	$ 0.1475 (-31.78%)	3.11M
PRTGPortage Biotech Inc	$ 0.3356 (-29.92%)	720.39k
CRKNCrown Electrokinetics Corporation	$ 0.1206 (20.60%)	194.86M
FFIEFaraday Future Intelligent Electric Inc	$ 0.6215 (6.53%)	140.1M
MBOTMicrobot Medical Inc	$ 2.29 (129.00%)	86.76M
BPTHBio Path Holdings Inc	$ 3.18 (54.37%)	45.02M
SQQQProShares UltraPro Short QQQ	$ 9.9099 (-1.10%)	38.74M